Skip to main content

Table 1 Demographic and clinical characteristics of VL patients

From: High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis

Variables (pre-treatment) VL patients (n = 45)
Age (mean ± SD) 15 ± 15 years
Males n (%) 25 (55.5%)
Spleen size (mean ± SD) 9.1 ± 4.08
White blood cell count 3035 ± 1351
Neutrophils 1041 ± 745.2
Platelets 181, 21 ± 63,844
Hb 8.475 ± 1.264
Confirmatory of VL  
r  K39 (n = 45) 100%
L  eishmania culture (n = 17) 100%
Parasite load (n = 15) 100%
AST (mean ± SD) 119.6 ± 188.4U/ml
ALT (mean ± SD) 79.20 ± 103.4U/ml
  1. Hb hemoglobine.
  2. VL Visceral leishmaniasis.
  3. rK39 serological test specific for Kalazar.
  4. AST Aspartate aminotransferase.
  5. ALT Alanine aminotransferase.